Successful Transformation and Integration
Completed first full year operating as a paperboard-focused business; successfully integrated the Augusta Mill and completed separation of the tissue business ahead of schedule, enabling higher shipments and portfolio focus.
Net Sales Growth
Full-year net sales of $1,600,000,000, an increase of 12% year-over-year driven primarily by operating the Augusta Mill for a full year.
Shipment Increase
Shipments increased approximately 14% year-over-year, primarily attributable to the Augusta Mill contribution.
Adjusted EBITDA Improvement
Adjusted EBITDA from continuing operations was $107,000,000 for the full year, up $71,000,000 versus prior year (an increase of ~197% versus the prior-year base of ~$36M), driven by cost control, higher volumes and lower input costs.
Material Fixed Cost and SG&A Reductions
Delivered more than $50,000,000 in fixed cost reductions including $16,000,000 in SG&A savings; SG&A declined to 6.5% of net sales from 8.4% in 2024 (a ~1.9 percentage-point improvement).
Improved Outage Execution and Lower Maintenance Spend
Completed all three major maintenance outages on schedule with total direct costs of $50,000,000 for the year, significantly lower than 2024 due to improved planning and execution.
Strong Liquidity and Balance Sheet
Ended the year with more than $400,000,000 in liquidity, supporting options to maintain flexibility (including refinancing 2020 notes due August 2027).
Insurance Recovery and Q4 Results
Received initial representation & warranty insurance settlement of $23,000,000 (with $6,000,000 related to 2025 operating costs) and Q4 net income from continuing operations of $3,000,000 ($0.20 per diluted share). Q4 adjusted EBITDA from continuing operations was $20,000,000, above the guidance midpoint.
Product & Growth Initiatives
Preparing to launch VOLURA lightweight paperboard in Q2 and completed engineering feasibility for a potential CUK conversion at Cypress Bend (estimated $60,000,000 capex, 12–18 month timeline) targeting 100,000–150,000 tons capture; continuing evaluation of CRB additions.
Capital Allocation Discipline
Repurchased $17,000,000 of shares in 2025 and retains $79,000,000 remaining under authorization; 2026 planned capex $65,000,000–$75,000,000 and expected working capital improvement of ~$20,000,000.